Eric Dobmeier, President, CEO at CHINOOK THERAPEUTICS, INC. (KDNY), bought 2,000 shares at $13.50 ($27K) on 2020-11-19, disclosed to the SEC on 2020-11-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.50 | 500 | $7K | 24.8% |
| 2 | $13.69 | 571 | $8K | 28.7% |
| 3 | $13.67 | 929 | $13K | 46.6% |
| Total | $13.63 avg | 2,000 | $27K | 100% |
| Filing → |
| KDNY | SELL | 2023-02-15 | $385K | — | Filing → |
| KDNY | SELL | 2023-02-01 | $993K | — | Filing → |
| KDNY | SELL | 2022-12-02 | $669K | — | Filing → |